Systemic microRNA profiles associated with coronary plaque stability and clinical phenotypes in patients with coronary artery disease
Clinical and Translational Discovery · 2026-04 · 6 (2)
DOI: 10.1002/ctd2.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Discovery, online erschienen am 16.04.2026. Verfasst von Souhir Wassaifi und 5 weiteren Autor:innen. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The development of coronary artery disease (CAD) and plaque destabilization are caused by endothelial dysfunction, inflammation and hypoxia. Recent studies suggest that circulating microRNAs (miRNAs) constitute promising non‐invasive biomarkers for monitoring these pathophysiological mechanisms.
Methods
In this exploratory study, we profiled circulating miRNAs in patients with stable versus unstable CAD and investigated the associations with plaque instability, comorbidities and sex‐specific modulation.
Results
Different expression patterns were observed. miR‐320‐3p was nominally reduced in unstable CAD, consistent with its role in endothelial integrity and blood coagulation, but this reduction was not statistically significant after correction. Sex‐specific increases in miR‐21 isoforms and miR‐210 were observed in women with unstable CAD, suggesting hormonal and inflammatory influences. Different associations of miR‐103a‐5p and miR‐146b‐5p with metabolic stress, as well as an accumulation of inflammatory, metabolic and hypoxia‐responsive miRNAs, underscore the presence of coordinated regulatory networks.
Conclusions
This pilot study identified circulating miRNA signatures associated with plaque instability and sex‐dependent vascular modulation. Although these results are preliminary, they provide a mechanistic and translational framework for integrating circulating miRNAs into multimodal risk stratification, thus complementing imaging techniques and conventional biomarkers. Larger longitudinal studies are needed to confirm predictive value and clinical utility.
Zitieren
APA
Wassaifi, S., Rahali, N., Finsterer, J., Lahidheb, D., Kaeffer, B., & Zarrouk, S. (2026). Systemic microRNA profiles associated with coronary plaque stability and clinical phenotypes in patients with coronary artery disease. Clinical and Translational Discovery, 6(2). https://doi.org/10.1002/ctd2.70115
Vancouver
Wassaifi S, Rahali N, Finsterer J, Lahidheb D, Kaeffer B, Zarrouk S. Systemic microRNA profiles associated with coronary plaque stability and clinical phenotypes in patients with coronary artery disease. Clinical and Translational Discovery. 2026;6(2). doi:10.1002/ctd2.70115
BibTeX
@article{Wassaifi2026,
author = {Wassaifi, Souhir and Rahali, Nadia and Finsterer, Josef and Lahidheb, Dhaker and Kaeffer, Bertrand and Zarrouk, Sinda},
title = {Systemic microRNA profiles associated with coronary plaque stability and clinical phenotypes in patients with coronary artery disease},
journal = {Clinical and Translational Discovery},
year = {2026},
volume = {6},
number = {2},
doi = {10.1002/ctd2.70115}
}
EUVIMED